| Literature DB >> 22093232 |
Bixia Gao1, Ling Zhu, Yingzi Pan, Shuwen Yang, Luxia Zhang, Haiyan Wang.
Abstract
BACKGROUND: Previous study indicated a high prevalence of ocular fundus pathology among patients with chronic kidney disease (CKD), while the relationship between them has never been explored in a Chinese Population.Entities:
Mesh:
Year: 2011 PMID: 22093232 PMCID: PMC3240828 DOI: 10.1186/1471-2369-12-62
Source DB: PubMed Journal: BMC Nephrol ISSN: 1471-2369 Impact factor: 2.388
Characteristics of the participants by status of ocular fundus examination.
| Any ocular fundus pathology | Retinopathy | ||||
|---|---|---|---|---|---|
| Yes (n = 2037) | No (n = 7607) | P value | Yes (n = 1670) | P value* | |
| Age (year) | 67.9 ± 11.4 | 48.8 ± 14.7 | <0.001 | 69.2 ± 9.9 | <0.001 |
| Male (%) | 67.2 | 59.8 | <0.001 | 68.3 | <0.001 |
| BMI (kg/m2) | 25.0 ± 3.4 | 24.3 ± 3.4 | <0.001 | 25.2 ± 3.4 | <0.001 |
| Hypertension (%) | 60.0 | 23.3 | <0.001 | 63.8 | <0.001 |
| Diabetes (%) | 20.2 | 7.3 | <0.001 | 21.5 | <0.001 |
| Cardiovascular disease (%) | 14.4 | 3.3 | <0.001 | 15.7 | <0.001 |
| LDL-cholesterol (mg/dL) | 3.0 ± 0.8 | 2.9 ± 0.8 | <0.001 | 3.0 ± 0.8 | <0.001 |
| HDL-cholesterol (mg/dL) | 1.4 ± 0.3 | 1.3 ± 0.3 | 0.56 | 1.34 ± 0.3 | 0.57 |
| Triglycerides (mg/dL) | 1.6 ± 1.1 | 1.6 ± 1.3 | 0.02 | 1.7 ± 1.0 | 0.02 |
| Plasma UA (mg/dL) | 5.8 ± 1.5 | 5.5 ± 1.5 | <0.001 | 5.8 ± 1.5 | <0.001 |
| eGFR (mL/min/1.73m2) | 81.9 ± 15.3 | 98.0 ± 16.2 | <0.001 | 81.0 ± 14.6 | <0.001 |
| eGFR<60 mL/min/1.73m2 (%) | 9.1 | 2.3 | <0.001 | 9.0 | <0.001 |
| Proteinuria (%) | 14.8 | 10.2 | <0.001 | 15.6 | <0.001 |
| Chronic kidney disease (%) | 21.0 | 11.9 | <0.001 | 21.7 | <0.001 |
* Compared with participants without any ocular fundus pathology.
BMI, body mass index; LDL, low-density lipoprotein; HDL, high-density lipoprotein; UA, uric acid; eGFR, estimated glomerular filtration rate.
The association between indicators of kidney damage with ocular fundus pathology.
| eGFR ((mL/min/1.73m2) | Proteinuria | CKD | |||
|---|---|---|---|---|---|
| ≥90 | 60-89 | <60 | |||
| Any ocular fundus pathology | |||||
| Crude OR (95% CI) | Reference | 5.18 (4.64-5.77) | 9.12 (7.30-11.38) | 1.53 (1.33-1.77) | 1.96 (1.73-2.23) |
| Age-, sex- adjusted OR (95% CI) | Reference | 1.03 (0.89-1.19) | 1.26 (0.96-1.65) | 1.45 (1.22-1.73) | 1.36 (1.17-1.59) |
| Fully adjusted OR (95% CI)* | Reference | 0.97 (0.84-1.13) | 1.07 (0.79-1.45) | 1.29 (1.07-1.55) | 1.18 (0.99-1.41) |
| Retinopathy | |||||
| Crude OR (95% CI) | Reference | 5.87 (5.20-6.62) | 7.76 (7.77-12.45) | 1.63 (1.40-1.90) | 2.05 (1.79-2.34) |
| Age-, sex- adjusted OR (95% CI) | Reference | 0.96 (0.82-1.12) | 1.05 (0.78-1.40) | 1.55 (1.28-1.87) | 1.38 (1.17-1.64) |
| Fully adjusted OR (95% CI)* | Reference | 0.91 (0.77-1.07) | 0.92 (0.66-1.27) | 1.37 (1.12-1.67) | 1.19 (0.98-1.44) |
* Covariates included in the fully adjusted models were: age (continuous), sex, BMI (<18.5, 18.5-24.9, 25.0-27.0, ≥27.0; kg/m2), hypertension (yes/no), diabetes (yes/no), history of CVD (yes/no)), plasma uric acid (continuous).
The number of participants with any ocular fundus pathology and retinopathy was 2037 and 1670, respectively.
eGFR: estimated glomerular filtration rate; CKD, chronic kidney disease; OR, odds ratio; CI, confidence interval.